Mei Pharma Terminates Lease Five Years Early to Cut Costs

Dow Jones06-26
 

By Sabela Ojea

 

Mei Pharma said it's terminating a San Diego lease more than five years in advance as part of a push to reduce its costs.

The oncology-focused biotechnology company on Tuesday said that the lease will be terminated on Sept. 30, instead of on Nov. 30, 2029.

The decision to will result in a reduction of annual average operating expenses of about $2.6 million after paying the landlord a termination fee of $11.1 million, Mei Pharma said.

The news come less than two months after the company reported no revenue in the third quarter of the year, and a narrowed loss of $9.1 million, or $1.37 a share.

 

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

 

(END) Dow Jones Newswires

June 25, 2024 17:55 ET (21:55 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment